Xiaofeng Li
81 Meishan Road
Hefei, 230032, China
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
METTL3 Promotes Activation and Inflammation of FLSs Through the NF-κB Signaling Pathway in Rheumatoid Arthritis.
Journal: Frontiers in medicine
Published: October 04, 2020
MicroRNA-141-5p Acts as a Tumor Suppressor via Targeting RAB32 in Chronic Myeloid Leukemia.
Journal: Frontiers in pharmacology
Published: August 14, 2019
MAST3 modulates the inflammatory response and proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.
Journal: International immunopharmacology
Published: June 26, 2019
PSTPIP2 Inhibits the Inflammatory Response and Proliferation of Fibroblast-Like Synoviocytes in vitro.
Journal: Frontiers in pharmacology
Published: September 06, 2018
A potential adjuvant chemotherapeutics, 18β-glycyrrhetinic acid, inhibits renal tubular epithelial cells apoptosis via enhancing BMP-7 epigenetically through targeting HDAC2.
Journal: Scientific reports
Published: October 19, 2015
Molecular mechanism of ER stress-induced gene expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in macrophages.
Journal: The FEBS journal
Published: October 12, 2014
Inhibition of transient receptor potential melastatin 7 (TRPM7) channel induces RA FLSs apoptosis through endoplasmic reticulum (ER) stress.
Journal: Clinical rheumatology
Published: January 23, 2014
Hypoxia-induced transcription factor 1α: a potent driving force behind rheumatoid arthritis.
Journal: Clinical and experimental rheumatology
Published: December 08, 2013
Toll-like receptor-4 signaling: a new potential therapeutic pathway for rheumatoid arthritis.
Journal: Rheumatology international
Published: September 10, 2013
Toll-like receptor (TLR)-3: a potent driving force behind rheumatoid arthritis.
Journal: Clinical rheumatology
Published: August 25, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026